Fruth Investment Management Abbott Laboratories Transaction History

Fruth Investment Management

$385 Million
Q3 2024

A detailed history of Fruth Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Fruth Investment Management holds 30,716 shares of ABT stock, worth $3.53 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

30,716

Previous 31,466 2.38%

Holding current value

$3.53 Million

Previous $3.27 Million 7.1%

% of portfolio

0.91%

Previous 0.89%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$100.07 - $118.13 $75,052 - $88,597	-750 Reduced 2.38%	30,716 $3.5 Million
Q2 2024 Jul 18, 2024	SELL	$100.73 - $112.44 $97,808 - $109,179	-971 Reduced 2.99%	31,466 $3.27 Million
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $28,475 - $31,449	-260 Reduced 0.8%	32,437 $3.69 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $12,705 - $15,244	-133 Reduced 0.41%	32,697 $3.17 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $403 - $449	-4 Reduced 0.01%	32,830 $3.58 Million
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $678 - $798	-7 Reduced 0.02%	32,834 $3.32 Million
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $23,765 - $27,880	-250 Reduced 0.76%	32,841 $3.61 Million
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $31,930 - $36,969	-330 Reduced 0.99%	33,091 $3.2 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $22,455 - $27,141	-220 Reduced 0.65%	33,421 $4.02 Million
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $6,271 - $7,647	-55 Reduced 0.16%	33,641 $3.98 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $5,314 - $6,507	-46 Reduced 0.14%	33,696 $4.74 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $14,582 - $16,132	-125 Reduced 0.37%	33,742 $3.99 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $47,889 - $56,421	-440 Reduced 1.28%	33,867 $4.06 Million
Q4 2020 Jan 13, 2021	SELL	$105.0 - $114.42 $94,500 - $102,978	-900 Reduced 2.56%	34,307 $3.76 Million
Q3 2020 Oct 07, 2020	SELL	$91.64 - $111.29 $73,312 - $89,032	-800 Reduced 2.22%	35,207 $3.83 Million
Q2 2020 Jul 13, 2020	BUY	$76.57 - $98.0 $34,456 - $44,100	450 Added 1.27%	36,007 $3.29 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $34,739 - $50,798	553 Added 1.58%	35,557 $2.81 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $50,481 - $56,198	-643 Reduced 1.8%	35,004 $3.04 Million
Q3 2019 Oct 09, 2019	SELL	$81.84 - $88.74 $8,184 - $8,874	-100 Reduced 0.28%	35,647 $2.98 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $1,822 - $2,125	-25 Reduced 0.07%	35,747 $3.01 Million
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $79,464 - $96,072	-1,200 Reduced 3.25%	35,772 $2.86 Million
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $32,780 - $37,135	-500 Reduced 1.33%	36,972 $2.67 Million
Q3 2018 Oct 10, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 0.27%	37,472 $2.75 Million
Q1 2018 May 01, 2018	SELL	$56.27 - $63.62 $74,782 - $84,550	-1,329 Reduced 3.42%	37,572 $2.25 Million
Q4 2017 Jan 09, 2018	SELL	$53.68 - $57.47 $60,658 - $64,941	-1,130 Reduced 2.82%	38,901 $2.22 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $1.92 Million - $2.15 Million	40,031	40,031 $2.14 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fruth Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Fruth Investment Management with notifications on news.

Account

Fruth Investment Management Abbott Laboratories Transaction History